Few significant analysis results was noted, when the risk of thyroid dysfunction of grades 3-5 was assessed.<h4>Conclusion</h4>Whether used alone or in combination with other anti-tumor drugs, PD-1/PD-L1 inhibitors increased the risk of thyroid dysfunction, especially for hypothyroidism. This evidence concerns the gene CD274 and hypothyroidism.